[HTML][HTML] Hypokalemia-induced arrhythmias and heart failure: new insights and implications for therapy

J Skogestad, JM Aronsen - Frontiers in physiology, 2018 - frontiersin.org
J Skogestad, JM Aronsen
Frontiers in physiology, 2018frontiersin.org
Routine use of diuretics and neurohumoral activation make hypokalemia (serum K+< 3. 5
mM) a prevalent electrolyte disorder among heart failure patients, contributing to the
increased risk of ventricular arrhythmias and sudden cardiac death in heart failure. Recent
experimental studies have suggested that hypokalemia-induced arrhythmias are initiated by
the reduced activity of the Na+/K+-ATPase (NKA), subsequently leading to Ca 2+ overload,
Ca 2+/Calmodulin-dependent kinase II (CaMKII) activation, and development of …
Routine use of diuretics and neurohumoral activation make hypokalemia (serum K+ < 3. 5 mM) a prevalent electrolyte disorder among heart failure patients, contributing to the increased risk of ventricular arrhythmias and sudden cardiac death in heart failure. Recent experimental studies have suggested that hypokalemia-induced arrhythmias are initiated by the reduced activity of the Na+/K+-ATPase (NKA), subsequently leading to Ca2+ overload, Ca2+/Calmodulin-dependent kinase II (CaMKII) activation, and development of afterdepolarizations. In this article, we review the current mechanistic evidence of hypokalemia-induced triggered arrhythmias and discuss how molecular changes in heart failure might lower the threshold for these arrhythmias. Finally, we discuss how recent insights into hypokalemia-induced arrhythmias could have potential implications for future antiarrhythmic treatment strategies.
Frontiers
以上显示的是最相近的搜索结果。 查看全部搜索结果